CTSL and Parkinson disease: Based on the data from the GD fibroblast cells and dopaminergic neuronal PD model of GCase deficiency, we propose that inhibition of cathepsin L may represent a potential therapeutic strategy for PD and related disorders that exhibit deficiency in lysosomal GCase activity.